The Bifidobacterium species B. longum was reported to be enriched in patients with non-small cell lung carcinoma (NSCLC) who responded to anti-PD1 treatment accompanied by higher levels of memory CD8+ T cells and natural killer (NK) T cells in their blood [15]. Here, PDCD1 is linked to non-small cell lung carcinoma.